BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19925394)

  • 1. Targeting prostate cancer stem cells.
    Crea F; Mathews LA; Farrar WL; Hurt EM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1105-13. PubMed ID: 19925394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
    Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
    Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell: target for anti-cancer therapy.
    Tang C; Ang BT; Pervaiz S
    FASEB J; 2007 Dec; 21(14):3777-85. PubMed ID: 17625071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
    Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
    Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma.
    Dubrovska A; Elliott J; Salamone RJ; Kim S; Aimone LJ; Walker JR; Watson J; Sauveur-Michel M; Garcia-Echeverria C; Cho CY; Reddy VA; Schultz PG
    Clin Cancer Res; 2010 Dec; 16(23):5692-702. PubMed ID: 21138868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cancer stem cells as an important target in liver cancer therapies.
    Zou GM
    Anticancer Agents Med Chem; 2010 Feb; 10(2):172-5. PubMed ID: 20298161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective targeting of cancer stem cells: a new concept in cancer therapeutics.
    Korkaya H; Wicha MS
    BioDrugs; 2007; 21(5):299-310. PubMed ID: 17896836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agents targeting prostate cancer bone metastasis.
    Mohammad KS; Fournier PG; Guise TA; Chirgwin JM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1079-88. PubMed ID: 19719455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer stem cells: a new target for therapy.
    Maitland NJ; Collins AT
    J Clin Oncol; 2008 Jun; 26(17):2862-70. PubMed ID: 18539965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
    Jaworska D; Szliszka E
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.
    Sabnis NG; Miller A; Titus MA; Huss WJ
    Mol Cancer Res; 2017 Feb; 15(2):128-140. PubMed ID: 27856956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers targeting cancer stem cells: how to help drugs to find their way home.
    Visani G; Loscocco F; Isidori A
    Nanomedicine (Lond); 2015; 10(7):1043-6. PubMed ID: 25929562
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting the acute myeloid leukemia stem cells.
    Krause A; Luciana M; Krause F; Rego EM
    Anticancer Agents Med Chem; 2010 Feb; 10(2):104-10. PubMed ID: 20184541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
    Pollyea DA; Gutman JA; Gore L; Smith CA; Jordan CT
    Haematologica; 2014 Aug; 99(8):1277-84. PubMed ID: 25082785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in the study of targeted drug delivery systems for cancer stem cells].
    Qiao MX; Zhang XJ; Shuang BA; Hu HY; Zhao XL; Chen DW
    Yao Xue Xue Bao; 2013 Apr; 48(4):477-83. PubMed ID: 23833932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
    El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
    PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.